Combined pulmonary fibrosis and emphysema in connective tissue disease

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 5, 2012, Pages 418-427

  Cottin, Vincent ^a   Cordier, Jean François ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

emphysema; pulmonary fibrosis; pulmonary hypertension; rheumatoid arthritis; systemic sclerosis

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CORTICOSTEROID; FIBRILLIN 1; OXYGEN; PREDNISONE; PROTEIN C;

CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DYSPNEA; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE MUTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LUNG AUSCULTATION; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION; LUNG VOLUME; OXYGEN THERAPY; PATHOGENESIS; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; SMOKING; SMOKING CESSATION; SYSTEMIC SCLEROSIS;

COMORBIDITY; CONNECTIVE TISSUE DISEASES; HUMANS; LUNG; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; SMOKING; SYNDROME;

EID: 84864869958     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328356803b     Document Type: Review

References (103)

1. Raghu G, Meyer KC. Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for antireflux therapy? Eur Respir J 2012; 39:242-245.
2. Fell CD. Idiopathic pulmonary fibrosis: phenotypes and comorbidities. Clin Chest Med 2012; 33:51-57.
3. Akira M, Yamamoto S, Inoue Y, Sakatani M. High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. AJR Am J Roentgenol 2003; 181:163-169. (Pubitemid 36741478)
4. Copley SJ, Wells AU, Sivakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology 2003; 229:731-736. (Pubitemid 37467577)
5. Doherty MJ, Pearson MG, O'Grady EA, et al. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997; 52:998-1002. (Pubitemid 27514497)
6. Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010; 188:365-373
7. Kurashima K, Takayanagi N, Tsuchiya N, et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 2010; 15:843-848.
8. Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emph ysema decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136:10-15.
9. chmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011; 38:176-183.
10. ankowich MD, Rounds SIS. Combined pulmonary fibrosis and emphysema syndrome. A review. Chest 2012; 141:222-231.
11. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26:586-593. (Pubitemid 41448654)
12. Balbi B, Cottin V, Singh S, et al. Smoking-related lung diseases: a clinical perspective. Eur Respir J 2010; 35:231-233.
13. Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136:1-2.
14. Dransfield MT, Washko GR, Foreman MG, et al. Gender differences in the severity of CT emphysema in COPD. Chest 2007; 132:464-470. (Pubitemid 47282377)
15. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:810-816. (Pubitemid 44511663)
16. Kting TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378:1949-1961.
17. du Bois RM, Weycker D, Albera C, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 184:459-466.
18. Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res 2012; 13:3.
19. Cottin V, Reix P, Khouatra C, et al. Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation. Thorax 2011; 66:918-919.
20. Cottin V, Cordier JF. SFTPC mutations in patients with familial pulmonary fibrosis: Combined with emphysema? Am J Respir Crit Care Med 2011; 183:1113.
21. van Moorsel CH, van Oosterhout MF, Barlo NP, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med 2010; 182:1419-1425.
22. Alder JK, Guo N, Kembou F, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 2011; 184:904-912.
23. Daniil Z, Koutsokera A, Gourgoulianis K. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J 2006; 27:434. (Pubitemid 43180924)
24. Leigh J, Driscoll TR, Cole BD, et al. Quantitative relation between emphysema and lung mineral content in coal workers. Occup Environ Med 1994; 51:400-407. (Pubitemid 24195246)
25. Heppleston AG. The pathological recognition and pathogenesis of emphysema and fibrocystic disease of the lung with special reference to coal workers. Ann N Y Acad Sci 1972; 200:347-369.
26. Marchiori E, Lourenco S, Gasparetto TD, et al. Pulmonary talcosis: imaging findings. Lung 2010; 188:165-171.
27. Porru S, Placidi D, Quarta C, et al. The potential role of rare earths in the pathogenesis of interstitial lung disease: a case report of movie projectionist as investigated by neutron activation analysis. J Trace Elem Med Biol 2001; 14:232-236. (Pubitemid 32476002)
28. Copley SJ, Lee YC, Hansell DM, et al. Asbestos-induced and smokingrelated disease: Apportioning pulmonary function deficit by using thin-section CT. Radiology 2007; 242:258-266. (Pubitemid 44956032)
29. Huuskonen O, Kivisaari L, Zitting A, et al. Emphysema findings associated with heavy asbestos-exposure in high resolution computed tomography of Fnnish construction workers. J Occup Health 2004; 46:266-271. (Pubitemid 39100156)
30. Begin R, Filion R, Ostiguy G. Emphysema in silica-and asbestos-exposed workers seeking compensation. A CT scan study. Chest 1995; 108:647-655.
31. Gerke AK, van Beek E, Hunninghake GW. Smoking inhibits the frequency of bronchovascular bundle thickening in sarcoidosis. Acad Radiol 2011; 18:885-891.
32. Cormier Y, Brown M, Worthy S, et al. High-resolution computed tomographic characteristics in acute farmer's lung and in its follow-up. Eur Respir J 2000; 16:56-60. (Pubitemid 30480128)
33. Erkinjuntti-Pekkanen R, Rytkonen H, Kokkarinen JI, et al. Long term risk of emphysema in patients with farmer's lung and matched control farmers. Am J Respir Crit Care Med 1998; 158:662-665. (Pubitemid 28378199)
34. ottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63:295-304.
35. Cottin V, Freymond N, Cabane J, Cordier JF. Combined pulmonary fibrosis and emphysema syndrome in a patient aged 28 years with severe systemic sclerosis. J Rheumatol 2011; 38:2082-2083.
36. ntin-Ozerkis D, Rubinowitz A, Evans J, et al. Interstitial lung disease in the connective tissue diseases. Clin Chest Med 2012; 33:123-149.
37. Aduen JF, Zisman DA, Mobin SI, et al. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc 2007; 82:48-54. (Pubitemid 46043228)
38. Kiakouama L, Cottin V, Glerant JC, et al. Conditions associated with severe carbon monoxide diffusion coefficient reduction. Respir Med 2011; 105:1248-1256.
39. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35:105-111.
40. Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15: 265-271.
41. Mura M, Zompatori M, Pacilli AM, et al. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 2006; 51:257-265. (Pubitemid 46888402)
42. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: The value of high resolution computed tomography in assessment. Respir Med 1990; 84:365-369. (Pubitemid 20287410)
43. Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 2009; 103:1209-1215.
44. Kishaba T, Shimaoka Y, Fukuyama H, et al. A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. BMJ Open 2012; 2:pii: e000988.
45. Hwang J-H, Misumi S, Sahin H, et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: Comparison with pulmonary fibrosis related to collagen vascular disease. J Comput Assist Tomogr 2009; 33:410-415.
46. Song JW, Do K-H, Kim M-Y, et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009; 136:23-30.
47. Dawson JK, Fewins HE, Desmond J, et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001; 56:622-627. (Pubitemid 32706144)
48. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232:81-91. (Pubitemid 38796446)
49. ischer A, Solomon JJ, du Bois RM, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 2012; 106:1040-1047.
50. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232: 560-567. (Pubitemid 38971300)
51. Hudson M, Lo E, Lu Y, et al. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2011; 63:230-238.
52. Lakhanpal S, Lie JT, Conn DL, Martin WJ 2nd. Pulmonary disease in polymyositis/dermatomyositis: A clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987; 46:23-29. (Pubitemid 17225125)
53. Antoniou KM, Hansell DM, Rubens M, et al. Association between emphysema and pulmonary fibrosis are suggestive of a smoking pathogenesis common to both disorders [abstract]. Am J Respir Crit Care Med 2008; 177:745S.
54. Cottin V, Thivolet-Béjui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003; 22:245-250. (Pubitemid 36986992)
55. Corte TJ, Copley SJ, Desai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39:661-668.
56. ij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011; 140:1292-1299.
57. Fischer A, West SG, Swigris JJ, et al. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138:251-256.
58. Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172:1146-1152. (Pubitemid 43066651)
59. Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008; 177:190-194.
60. Hammond EC, Auerbach O, Kirman D, Garfinkel L. Effects of cigarette smoking on dogs. Arch Environ Health 1970; 21:740-753.
61. Cottin V, Fabien N, Khouatra C, et al. Antielastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Eur Respir J 2009; 33:219-221.
62. Antoniou KM, Margaritopoulos G, Desai SR, et al. Pulmonary fibrosis is associated with emphysema in systemic sclerosis: indirect support for a smoking pathogenesis hypothesis [abstract]. Am J Respir Crit Care Med 2009; 180:494S.
63. Albano SA, Santana-Sahagun E, Weisman MH. Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 2001; 31:146-159. (Pubitemid 33140641)
64. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54:38-46. (Pubitemid 43122184)
65. Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003; 62:722-727. (Pubitemid 36886405)
66. Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc 2007; 4:443-448. (Pubitemid 47435369)
67. Kim EJ, Collard HR, King TE Jr. Rheumatoid arthritis-associated interstitial lung disease: The relevance of histopathologic and radiographic pattern. Chest 2009; 136:1397-1405.
68. Harel-Meir M, Sherer Y, Shoenfeld Y. Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol 2007; 3:707-715. (Pubitemid 350187016)
69. Szapiel SV, Fulmer JD, HunninghakeGW, et al. Hereditary emphysema in the tight-skin (TSK/) mouse. Am Rev Respir Dis 1981; 123:680-685. (Pubitemid 11117592)
70. Martorana PA, Wilkinson M, van Even P, Lungarella G. TSK mice with genetic emphysema. Right ventricular hypertrophy occurs without hypertrophy of muscular pulmonary arteries or muscularization of arterioles. Am Rev Respir Dis 1990; 142:333-337. (Pubitemid 20235940)
71. Cottin V, Cordier JF. Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. Am J Respir Crit Care Med 2005; 172:1605. (Pubitemid 43076555)
72. Wert SE, Yoshida M, LeVine AM, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 2000; 97:5972-5977. (Pubitemid 30367508)
73. Lundblad LK, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factoralpha overexpression in lung disease: A single cause behind a complex phenotype. Am J Respir Crit Care Med 2005; 171:1363-1370. (Pubitemid 40800508)
74. Lucatelli M, Bartalesi B, Cavarra E, et al. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res 2005; 6:83.
75. Couillin I, Vasseur V, Charron S, et al. IL-1r1/myd88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol 2009; 183:8195-8202.
76. Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32:311-318. (Pubitemid 40478306)
77. Samara KD, Margaritopoulos G, Wells AU, et al. Smoking and pulmonary fibrosis: novel insights. Pulm Med 2011; 2011:461439.
78. Tasaka S, Mizoguchi K, Funatsu Y, et al. Cytokine profile of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema. Respirology 2012; doi: 10.1111/j.1440-1843.2012.02182.x. [Epub ahead of print].
79. Jankowich MD, Polsky M, Klein M, Rounds S. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75:411-417. (Pubitemid 351685432)
80. Rogliani P, Mura M, Mattia P, et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med 2008; 102:1753-1761.
81. Marten K, Milne D, Antoniou KM, et al. Nonspecific interstitial pneumonia in cigarette smokers: A CT study. Eur Radiol 2009; 19:1679-1685.
82. Akira M, Inoue Y, Kitaichi M, et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thinsection CT findings. Radiology 2009; 251:271-279.
83. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis-evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824.
84. Brillet P, Cottin V, Letoumelin P, et al. Combined apical emphysema and basal fibrosis syndrome (emphysema/fibrosis syndrome): CT imaging features and pulmonary function tests. J Radiol 2009; 90:43-51.
85. Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009; 33:882-896.
86. Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165:1581-1586. (Pubitemid 34693935)
87. Hansell DM, Bankier AA, Macmahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246:697-722.
88. Suki B, Majumdar A, Parameswaran H, et al. A network model of combined pulmonary emphysema and fibrosis: effects of gravity [abstract]. Am J Respir Crit Care Med 2009; 179:A5938.
89. Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53:707-714. (Pubitemid 352768716)
90. Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol 2006; 19:1474-1479. (Pubitemid 44624167)
91. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010; 41:316-325.
92. Todd NW, Jeudy J, Lavania S, et al. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair 2011; 4:6.
93. Cottin V, Cordier JF, Wells AU. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response. Fibrogenesis Tissue Repair 2011; 4:16.
94. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008; 31:1357-1367.
95. Schiess R, Senn O, Fischler M, et al. Tobacco smoke: a risk factor for pulmonary arterial hypertension? A case-control study. Chest 2010; 138:1086-1092.
96. Ferrer E, Peinado VI, Castaneda J, et al. Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig. Eur Respir J 2011; 38:617-627.
97. Henno P, Boitiaux JF, Douvry B, et al. Tobacco-associated pulmonary vascular dysfunction in smokers: Role of the ET-1 pathway. Am J Physiol Lung Cell Mol Physiol 2011; 300:L831-L839.
98. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167:962-969. (Pubitemid 36408161)
99. Usui K, Tanai C, Tanaka Y, et al. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011; 16:326-331.
100. Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011; 37:356-363.
101. Saito H, Minamiya Y, Nanjo H, et al. Pathological finding of subclinical interstitial pneumonia as a predictor of postoperative acute respiratory distress syndrome after pulmonary resection. Eur J Cardiothorac Surg 2011; 39:190-194.
102. Saggar R, Khanna D, Furst DE, et al. Systemic sclerosis and bilateral lung transplantation: a single centre experience. Eur Respir J 2010; 36:893-900.
103. Wells AU, Behr J, Costabel U, et al. Triple therapy in idiopathic pulmonary fibrosis: an alarming press release. Eur Respir J 2012; 39:805-806.